Incoming Resources
- Bioassay of tolbutamide for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of emetine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of Aroclor® 1254 for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of isophosphamide for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 1,5-naphthalenediamine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of parathion for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of ICRF-159 for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2,4-diaminoanisole sulfate for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of dibromochloropropane for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of ethionamide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of hydrazobenzene for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of pentachloronitrobenzene for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of p-anisidine hydrochloride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 4-chloro-m-phenylenediamine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 6-nitrobenzimidazole for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2,3,5,6-tetrachloro-4-nitroanisole for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2-aminoanthraquinone for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of dapsone for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health ; prepared at Tracor Jitco
- Bioassay of 2,5-toluenediamine sulfate for possible carcinogenicity
- Bioassay of ethyl tellurac for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of o-anisidine hydrochloride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2,4,5-trimethylaniline for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of picloram for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 5-nitroacenaphthene for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of (2-chloroethyl) trimethylammonium chloride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of estradiol mustard for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of malathion for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of acetohexamide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Diet for a poisoned planet, how to choose safe foods for you and your family, David Steinman ; forword by William Marcus
- Betel quid with tobacco (gutka)
- Bioassay of tolazamide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of p-cresidine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of n-phenyl-p-phenylenediamine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of diarylanilide yellow for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of C.I. vat yellow 4 for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of triphenyltin hydroxide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of endrin for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of sulfallate for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of m-cresidine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of trisodium ethylenediaminetetraacetate trihydrate for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of phosphamidon for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of butylated hydroxytoluene (BHT) for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2-amino-5-nitrothiazole for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of chlordane for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Institutes of Health
- Bioassay of fenthion for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Guidelines for carcinogen bioassay in small rodents, James M. Sontag, Norbert P. Page, Umberto Saffiotti
- Bioassays of aldrin and dieldrin for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health. ; prepared at Tracor Jitco, inc
- Little changes, tales of a reluctant home eco-momics pioneer, Kristi Marsh ; in collaboration with Rachel Vidoni ; original illustrations by Kathryn Tempestoso
- 13-week subchronic toxicity studies, direct blue 6, direct black 38, and direct brown 95 dyes, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 1,1,2-trichloroethane for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health